TITLE

High expression and frequently humoral immune response of melanoma-associated antigen D4 in glioma

AUTHOR(S)
Shu-Jia He; Yong-Yao Gu; Liang Yu; Bin Luo; Rong Fan; Wen-Zhen Lin; Xiu-Wan Lan; Yong-Da Lin; Qing-Mei Zhang; Shao-Wen Xiao; Xiao-Xun Xie
PUB. DATE
May 2014
SOURCE
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 5, p2350
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
96450856

 

Related Articles

  • Intracutaneous Genetic Immunization with Autologous Melanoma-Associated Antigen Pmel17/gp100 Induces T Cell-Mediated Tumor Protection In Vivo. Wagner, Stephan N.; Wagner, Christine; Lührs, Petra; Weimann, Tatjana K.; Kutil, Raphaela; Goos, Manfred; Stingl, Georg; Schneeberger, Achim // Journal of Investigative Dermatology;Dec2000, Vol. 115 Issue 6, p1082 

    Summary Using the differentiation antigen Pmel17/gp100 to genetically immunize C57BL/6 mice (H-2b), we and colleagues noticed that only mice that had received the human homolog but not animals injected with the murine counterpart were protected against the growth of syngeneic B16 melanoma cells....

  • Myeloid-derived suppressor cells enhance the expression of melanoma-associated antigen A4 in a Lewis lung cancer murine model. GUILAN SHI; HUIRU WANG; XIUFEN ZHUANG // Oncology Letters;Jan2016, Vol. 11 Issue 1, p809 

    The cancer-testis (CT) family of antigens are expressed in multiple types of malignant neoplasm and are silent in normal tissues, apart from the testis. Immunotherapy targeting CT antigens is a promising therapeutic strategy for treatment of solid tumors. One member of this family,...

  • NEW GLIOMA-ASSOCIATED AUTO-ANTIBODIES. Fueyo, Juan; Conrad, Charles; Gomez-Manzano, Candelaria; Yung, WK Alfred; Tufaro, Frank; Lang, Frederick // Neuro-Oncology;Jul2014 Supplement, Vol. 16 Issue suppl_3, piii41 

    BACKGROUND: Accumulating evidence has demonstrated that the immune system can recognize the antigenic changes in cancer cells, and further develop autoantibodies against these tumor-associated antigens (TAAs). Therefore, these cancer-associated autoantibodies might be used to identify the...

  • Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model. Ciesielski, Michael; Kazim, A.; Barth, Rolf; Fenstermaker, Robert // Cancer Immunology, Immunotherapy;Feb2005, Vol. 54 Issue 2, p107 

    Human malignant gliomas contain epidermal growth factor receptor (EGFR) gene mutations that encode tumor-associated antigens (TAAs) that can be targeted using immunological techniques. One EGFR mutant gene (EGFRvIII) encodes a protein with an epitope that is not found in normal tissues. A number...

  • A DNA vaccine expressing tyrosinase-related protein-2 induces T-cell-mediated protection against mouse glioblastoma. InSug O; Blaszczyk-Thurin, Magdalena; Shen, Chunpang T; Ertl, Hildegund CJ // Cancer Gene Therapy;Sep2003, Vol. 10 Issue 9, p678 

    A mouse glioblastoma cell line, termed GL261, was shown to express high levels of proteins involved in melanin biosynthesis such as the tyrosinase-related protein-2 (TRP-2), which is commonly overexpressed in melanoma cells. Mice injected with GL261 cells developed a CD8+ T-cell response to...

  • Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses. Renner, Danielle N.; Jin, Fang; Litterman, Adam J.; Balgeman, Alexis J.; Hanson, Lisa M.; Gamez, Jeffrey D.; Chae, Michael; Carlson, Brett L.; Sarkaria, Jann N.; Parney, Ian F.; Ohlfest, John R.; Pirko, Istvan; Pavelko, Kevin D.; Johnson, Aaron J. // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Glioblastoma (GBM) is among the most invasive and lethal of cancers, frequently infiltrating surrounding healthy tissue and giving rise to rapid recurrence. It is therefore critical to establish experimental model systems and develop therapeutic approaches that enhance anti-tumor immunity. In...

  • A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Bins, Adriaan D.; Jorritsma, Annelies; Wolkers, Monika C.; Chien-Fu Hung; Wu, T.-C.; Schumacher, Ton N. M.; Haanen, John B. A. G. // Nature Medicine;Aug2005, Vol. 11 Issue 8, p899 

    Induction of immunity after DNA vaccination is generally considered a slow process. Here we show that DNA delivery to the skin results in a highly transient pulse of antigen expression. Based on this information, we developed a new rapid and potent intradermal DNA vaccination method. By...

  • Multiple variants and a differential splicing pattern of kinectin in human hepatocellular carcinoma. Hong-Cheng Wang; Yan-Rong Su; Ke-Jun Han; Xue-Wen Pang; Ji-Run Peng; Bin Liang; Shan Wang; Wei-Feng Chen // Biochemistry & Cell Biology;Apr2004, Vol. 82 Issue 2, p321 

    To extend the search for hepatocellular carcinoma (HCC) associated antigens with immunogenicity for clinical applications, we constructed a cDNA expression library using resected human HCC tissue sample and screened it by serological analysis of recombinant cDNA expression library (SEREX) with...

  • The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy. Smith, Heath A.; McNeel, Douglas G. // Clinical & Developmental Immunology;2010, p1 

    Cancer-testis antigens (CTAs) represent an expanding class of tumor-associated proteins defined on the basis of their tissuerestricted expression to testis or ovary germline cells and frequent ectopic expression in tumor tissue. The expression of CTA in MHC class I-deficient germline cells makes...

  • Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model. Ruf, Peter; Sch„fer, Beatrix; Eissler, Nina; Mocikat, Ralph; Hess, Juergen; Pl”scher, Matthias; Wosch, Susanne; Suckstorff, Ivonne; Zehetmeier, Christine; Lindhofer, Horst // Journal of Translational Medicine;2012, Vol. 10 Issue 1, p219 

    Background: Trifunctional bispecific antibodies (trAb) are a special class of bispecific molecules recruiting and activating T cells and accessory immune cells simultaneously at the targeted tumor. The new trAb Ektomab that targets the melanoma-associated ganglioside antigen GD2 and the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics